{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:16:24Z","timestamp":1792602984491,"version":"4.5.0"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012129","name":"Baker Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.semcancer.2015.07.004","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T04:53:53Z","timestamp":1438232033000},"page":"36-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Microenvironment abnormalities and lymphomagenesis: Immunological aspects"],"prefix":"10.1016","volume":"34","author":[{"given":"Joseph G.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Gribben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2015.07.004_bib0660","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/B978-0-12-800267-4.00003-1","article-title":"Recognition of tumors by the innate immune system and natural killer cells","volume":"122","author":"Marcus","year":"2014","journal-title":"Adv. Immunol."},{"issue":"4","key":"10.1016\/j.semcancer.2015.07.004_bib0665","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.4049\/jimmunol.1200965","article-title":"Ras activation induces expression of Raet1 family NK receptor ligands","volume":"189","author":"Liu","year":"2012","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.semcancer.2015.07.004_bib0670","doi-asserted-by":"crossref","first-page":"pe24438","DOI":"10.4161\/onci.24438","article-title":"ATM activation mediates anticancer immunosurveillance by natural killer and T cells","volume":"2","author":"Tang","year":"2013","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.semcancer.2015.07.004_bib0675","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.semcancer.2006.07.004","article-title":"The DNA damage response, immunity and cancer","volume":"16","author":"Gasser","year":"2006","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.semcancer.2015.07.004_bib0680","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1073\/pnas.0701675105","article-title":"Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance","volume":"105","author":"Unni","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.semcancer.2015.07.004_bib0685","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/eji.200939937","article-title":"Requirements for control of B-cell lymphoma by NK cells","volume":"40","author":"Brenner","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.semcancer.2015.07.004_bib0690","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/ijc.26191","article-title":"Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunction","volume":"131","author":"Andre","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"2B","key":"10.1016\/j.semcancer.2015.07.004_bib0695","first-page":"1263","article-title":"Development of cancer in patients with primary immunodeficiencies","volume":"28","author":"Salavoura","year":"2008","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.semcancer.2015.07.004_bib0700","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.4049\/jimmunol.165.7.3549","article-title":"cell activation in X-linked lymphoproliferative disease","volume":"165","author":"Benoit","year":"2000","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.semcancer.2015.07.004_bib0705","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ni.1763","article-title":"Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells","volume":"10","author":"Dong","year":"2009","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2015.07.004_bib0710","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/eji.201344312","article-title":"XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells","volume":"44","author":"Meazza","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.semcancer.2015.07.004_bib0715","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.virol.2013.04.037","article-title":"Viral protein R upregulates expression of ULBP2 on uninfected bystander cells during HIV-1 infection of primary CD4+ T lymphocytes","volume":"443","author":"Richard","year":"2013","journal-title":"Virology"},{"issue":"Pt 1","key":"10.1016\/j.semcancer.2015.07.004_bib0720","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1099\/vir.0.82125-0","article-title":"Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity","volume":"88","author":"Cerboni","year":"2007","journal-title":"J. Gen. Virol."},{"issue":"6","key":"10.1016\/j.semcancer.2015.07.004_bib0725","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1096\/fj.12-223057","article-title":"Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells","volume":"27","author":"Matusali","year":"2013","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.semcancer.2015.07.004_bib0730","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2010.05.014","article-title":"MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction","volume":"406","author":"Nolting","year":"2010","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.semcancer.2015.07.004_bib0735","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/v3071091","article-title":"The natural killer cell cytotoxic function is modulated by HIV-1 accessory proteins","volume":"3","author":"Sowrirajan","year":"2011","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.semcancer.2015.07.004_bib0740","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.immuni.2008.02.016","article-title":"NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy","volume":"28","author":"Guerra","year":"2008","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.semcancer.2015.07.004_bib0745","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2011-07-370841","article-title":"High ERp5\/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas","volume":"119","author":"Zocchi","year":"2012","journal-title":"Blood"},{"issue":"6908","key":"10.1016\/j.semcancer.2015.07.004_bib0750","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nature01112","article-title":"Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation","volume":"419","author":"Groh","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.semcancer.2015.07.004_bib0755","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cell.2011.12.031","article-title":"Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model","volume":"148","author":"Zhang","year":"2012","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.semcancer.2015.07.004_bib0760","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1182\/blood-2005-03-0918","article-title":"Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells","volume":"106","author":"Coudert","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.semcancer.2015.07.004_bib0765","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ni1239","article-title":"Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance","volume":"6","author":"Oppenheim","year":"2005","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.semcancer.2015.07.004_bib0770","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of beta2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.semcancer.2015.07.004_bib0775","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3324\/haematol.2011.058529","article-title":"Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions","volume":"97","author":"Espinoza","year":"2012","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.semcancer.2015.07.004_bib0780","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.ajpath.2013.01.015","article-title":"Protective roles of epithelial cells in the survival of adult T-cell leukemia\/lymphoma cells","volume":"182","author":"Miyatake","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"21","key":"10.1016\/j.semcancer.2015.07.004_bib0785","first-page":"6178","article-title":"Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity","volume":"62","author":"Pende","year":"2002","journal-title":"Cancer Res."},{"issue":"6832","key":"10.1016\/j.semcancer.2015.07.004_bib0790","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.semcancer.2015.07.004_bib0795","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1365-2559.2001.01039.x","article-title":"Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteria","volume":"38","author":"Canioni","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.semcancer.2015.07.004_bib0800","doi-asserted-by":"crossref","first-page":"918471","DOI":"10.1155\/2011\/918471","article-title":"Tumor evasion from T cell surveillance","volume":"2011","author":"Topfer","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"issue":"5","key":"10.1016\/j.semcancer.2015.07.004_bib0805","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1084\/jem.184.5.1781","article-title":"Decreased tumor surveillance in perforin-deficient mice","volume":"184","author":"van den Broek","year":"1996","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.semcancer.2015.07.004_bib0810","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.192.5.755","article-title":"Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma","volume":"192","author":"Smyth","year":"2000","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2015.07.004_bib0815","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.0105-2896.2010.00890.x","article-title":"Inherited defects in lymphocyte cytotoxic activity","volume":"235","author":"Pachlopnik Schmid","year":"2010","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.semcancer.2015.07.004_bib0820","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3324\/haematol.2012.073098","article-title":"Development of classical Hodgkin's lymphoma in an adult with biallelic STXBP2 mutations","volume":"98","author":"Machaczka","year":"2013","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.semcancer.2015.07.004_bib0825","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2004-04-1477","article-title":"A proportion of patients with lymphoma may harbor mutations of the perforin gene","volume":"105","author":"Clementi","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.semcancer.2015.07.004_bib0830","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1182\/blood-2005-07-2880","article-title":"Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2","volume":"107","author":"Godal","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.semcancer.2015.07.004_bib0835","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00277-013-1775-4","article-title":"Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma","volume":"92","author":"Bedewy","year":"2013","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.semcancer.2015.07.004_bib0840","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3835(00)00567-X","article-title":"Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas","volume":"160","author":"Ohshima","year":"2000","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.semcancer.2015.07.004_bib0845","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00432-009-0586-4","article-title":"Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP","volume":"135","author":"Hara","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.semcancer.2015.07.004_bib0850","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/labinvest.3780310","article-title":"Loss of Fas (CD95\/APO-1) regulatory function is an important step in early MALT-type lymphoma development","volume":"81","author":"Seeberger","year":"2001","journal-title":"Lab. Invest."},{"issue":"11","key":"10.1016\/j.semcancer.2015.07.004_bib0855","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.4049\/jimmunol.166.11.6473","article-title":"Cutting edge: cellular Fas-associated death domain-like IL-1-converting enzyme-inhibitory protein protects germinal center B cells from apoptosis during germinal center reactions","volume":"166","author":"van Eijk","year":"2001","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.semcancer.2015.07.004_bib0860","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1365-2559.2007.02882.x","article-title":"Expression of c-FLIP is primarily detected in diffuse large B-cell lymphoma and Hodgkin's lymphoma and correlates with lack of caspase 8 activation","volume":"51","author":"van Houdt","year":"2007","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.semcancer.2015.07.004_bib0865","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1182\/blood-2005-06-2567","article-title":"HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP)","volume":"107","author":"Krueger","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semcancer.2015.07.004_bib0870","first-page":"62","article-title":"Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation","volume":"4","author":"Belanger","year":"2001","journal-title":"J. Hum. Virol."},{"issue":"3","key":"10.1016\/j.semcancer.2015.07.004_bib0875","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI44417","article-title":"Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice","volume":"121","author":"Ballon","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2015.07.004_bib0880","doi-asserted-by":"crossref","first-page":"829525","DOI":"10.1155\/2011\/829525","article-title":"Inhibition of germinal centre apoptotic programmes by epstein-barr virus","volume":"2011","author":"Spender","year":"2011","journal-title":"Adv. Hematol."},{"issue":"4","key":"10.1016\/j.semcancer.2015.07.004_bib0885","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/0891693021000002072","article-title":"Inhibition of Fas-mediated apoptosis by antigen: implications for lymphomagenesis","volume":"35","author":"Schattner","year":"2002","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.semcancer.2015.07.004_bib0890","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1182\/blood-2007-05-085159","article-title":"PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma","volume":"111","author":"Yamamoto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2015.07.004_bib0895","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol. Rev."},{"issue":"7","key":"10.1016\/j.semcancer.2015.07.004_bib0900","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2012-02-411678","article-title":"Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer","volume":"120","author":"Ramsay","year":"2012","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.semcancer.2015.07.004_bib0905","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/leu.2014.84","article-title":"TGF-beta upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin's lymphoma","volume":"28","author":"Yang","year":"2014","journal-title":"Leukemia"},{"issue":"7338","key":"10.1016\/j.semcancer.2015.07.004_bib0910","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.semcancer.2015.07.004_bib0915","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","article-title":"Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy","volume":"18","author":"Green","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.semcancer.2015.07.004_bib0920","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.semcancer.2015.07.004_bib0925","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.3109\/10428194.2012.673228","article-title":"Contribution of PD-L1 to oncogenesis of lymphoma and its RNAi-based targeting therapy","volume":"53","author":"Li","year":"2012","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.semcancer.2015.07.004_bib0930","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/leu.2008.272","article-title":"PD-1\/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia\/lymphoma patients","volume":"23","author":"Kozako","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2015.07.004_bib0935","doi-asserted-by":"crossref","first-page":"p31","DOI":"10.1186\/1742-4690-10-31","article-title":"Molecular signatures of T-cell inhibition in HIV-1 infection","volume":"10","author":"Larsson","year":"2013","journal-title":"Retrovirology"},{"issue":"2","key":"10.1016\/j.semcancer.2015.07.004_bib0940","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1182\/blood-2015-02-626754","article-title":"Mechanisms of PD-L1\/PD-1-mediated CD8 T-cell dysfunction in the context of aging-related immune defects in the E\u03bc-TCL1 CLL mouse model","volume":"126","author":"McClanahan","year":"2015","journal-title":"Blood"},{"issue":"268","key":"10.1016\/j.semcancer.2015.07.004_bib0945","doi-asserted-by":"crossref","first-page":"268ra179","DOI":"10.1126\/scitranslmed.3009892","article-title":"mTOR inhibition improves immune function in the elderly","volume":"6","author":"Mannick","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.semcancer.2015.07.004_bib0950","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11912-015-0457-x","article-title":"The biology of aging and lymphoma: a complex interplay","volume":"17","author":"Sarkozy","year":"2015","journal-title":"Curr. Oncol. Rep."},{"issue":"7","key":"10.1016\/j.semcancer.2015.07.004_bib0955","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2006-04-015164","article-title":"Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients","volume":"108","author":"Gandhi","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.semcancer.2015.07.004_bib0960","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.4049\/jimmunol.1400557","article-title":"Too much of a good thing? Tim-3 and TCR signaling in T cell exhaustion","volume":"193","author":"Ferris","year":"2014","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2015.07.004_bib0965","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1084\/jem.20090397","article-title":"Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion","volume":"207","author":"Huang","year":"2010","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.semcancer.2015.07.004_bib0970","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1007\/s13277-014-2080-0","article-title":"Tim-3 expression is increased on peripheral T cells from diffuse large B cell lymphoma","volume":"35","author":"Xiao","year":"2014","journal-title":"Tumour Biol."},{"issue":"4","key":"10.1016\/j.semcancer.2015.07.004_bib0975","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10753-013-9605-3","article-title":"T-cell immunoglobulin- and mucin-domain-containing molecule 3 genetic variants and HIV+ non-Hodgkin lymphomas","volume":"36","author":"Song","year":"2013","journal-title":"Inflammation"},{"issue":"9","key":"10.1016\/j.semcancer.2015.07.004_bib0980","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/blood-2006-12-064360","article-title":"RNA fingerprints provide direct evidence for the inhibitory role of TGFbeta and PD-1 on CD4+ T cells in Hodgkin lymphoma","volume":"110","author":"Chemnitz","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semcancer.2015.07.004_bib0985","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cyto.2015.02.024","article-title":"Rapamycin can restore the negative regulatory function of transforming growth factor beta 1 in high grade lymphomas","volume":"73","author":"Sebestyen","year":"2015","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.semcancer.2015.07.004_bib0990","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ccr.2009.12.043","article-title":"Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence","volume":"17","author":"Reimann","year":"2010","journal-title":"Cancer Cell"},{"issue":"5\u20136","key":"10.1016\/j.semcancer.2015.07.004_bib0995","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3109\/10428190009059266","article-title":"The role of cytokines in the pathogenesis and management of AIDS-related lymphomas","volume":"38","author":"Fassone","year":"2000","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.semcancer.2015.07.004_bib1000","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1182\/blood-2006-11-059881","article-title":"Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells","volume":"111","author":"Flavell","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.semcancer.2015.07.004_bib1005","doi-asserted-by":"crossref","first-page":"a014290","DOI":"10.1101\/cshperspect.a014290","article-title":"The role of MIZ-1 in MYC-dependent tumorigenesis","volume":"3","author":"Wiese","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"9","key":"10.1016\/j.semcancer.2015.07.004_bib1010","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1128\/JVI.03642-13","article-title":"Repression of the proapoptotic cellular BIK\/NBK gene by Epstein-Barr virus antagonizes transforming growth factor beta1-induced B-cell apoptosis","volume":"88","author":"Campion","year":"2014","journal-title":"J. Virol."},{"issue":"28","key":"10.1016\/j.semcancer.2015.07.004_bib1015","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1038\/sj.onc.1210496","article-title":"Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways","volume":"26","author":"Wood","year":"2007","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.semcancer.2015.07.004_bib1020","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s12185-013-1345-5","article-title":"IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations","volume":"97","author":"Hosgood","year":"2013","journal-title":"Int. J. Hematol."},{"issue":"23","key":"10.1016\/j.semcancer.2015.07.004_bib1025","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1182\/blood-2013-06-508267","article-title":"A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency","volume":"122","author":"Neven","year":"2013","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.semcancer.2015.07.004_bib1030","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1182\/blood-2013-10-531657","article-title":"No immunosurveillance in human IL-10R deficiency","volume":"122","author":"Oft","year":"2013","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.semcancer.2015.07.004_bib1035","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/ijc.29326","article-title":"Inhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma","volume":"136","author":"Bernard","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2015.07.004_bib1040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/path.867","article-title":"Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease","volume":"194","author":"Beck","year":"2001","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.semcancer.2015.07.004_bib1045","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.4049\/jimmunol.174.5.3015","article-title":"Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma","volume":"174","author":"Ogden","year":"2005","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.semcancer.2015.07.004_bib1050","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2008-02-138933","article-title":"IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma","volume":"112","author":"Calvo","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.semcancer.2015.07.004_bib1055","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood-2012-04-421826","article-title":"High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells","volume":"121","author":"Myklebust","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2015.07.004_bib1060","doi-asserted-by":"crossref","first-page":"167501","DOI":"10.5402\/2011\/167501","article-title":"Hepatitis C virus-related lymphomagenesis in a mouse model","volume":"2011","author":"Tsukiyama-Kohara","year":"2011","journal-title":"ISRN Hematol."},{"issue":"43","key":"10.1016\/j.semcancer.2015.07.004_bib1065","doi-asserted-by":"crossref","first-page":"37368","DOI":"10.1074\/jbc.M111.255125","article-title":"Syk activation of phosphatidylinositol 3-kinase\/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus+ (EBV+) B cell lymphomas","volume":"286","author":"Hatton","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2015.07.004_bib1070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1196\/annals.1339.047","article-title":"Functional validation of genes implicated in lymphomagenesis: an in vivo selection assay using a Myc-induced B-cell tumor","volume":"1059","author":"Yu","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"7","key":"10.1016\/j.semcancer.2015.07.004_bib1075","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/QAD.0b013e328332d5b1","article-title":"Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study","volume":"24","author":"Wong","year":"2010","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.semcancer.2015.07.004_bib1080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.imlet.2011.01.009","article-title":"IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway","volume":"136","author":"Song","year":"2011","journal-title":"Immunol. Lett."},{"issue":"9","key":"10.1016\/j.semcancer.2015.07.004_bib1085","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/leu.2014.108","article-title":"The targeting of immunosuppressive mechanisms in hematological malignancies","volume":"28","author":"Andersen","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2015.07.004_bib1090","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1158\/1078-0432.CCR-14-2275","article-title":"Prognostic significance of tryptophan catabolism in adult T-cell leukemia\/lymphoma","volume":"21","author":"Masaki","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.semcancer.2015.07.004_bib1095","first-page":"1133","article-title":"Indoleamine 2,3-dioxygenasase (IDO) as a prognostic factor of hematological malignancies","volume":"59","author":"Hara","year":"2011","journal-title":"Rinsho Byori"},{"key":"10.1016\/j.semcancer.2015.07.004_bib1100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1471-2407-14-335","article-title":"Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study","volume":"14","author":"Choe","year":"2014","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2015.07.004_bib1105","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00277-010-1093-z","article-title":"Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"90","author":"Ninomiya","year":"2011","journal-title":"Ann. Hematol."},{"issue":"12","key":"10.1016\/j.semcancer.2015.07.004_bib1110","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1128\/JVI.03678-13","article-title":"Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38\/mitogen-activated protein kinase and NF-kappaB pathways: impairment in T cell functions","volume":"88","author":"Liu","year":"2014","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.semcancer.2015.07.004_bib1115","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.molimm.2006.03.006","article-title":"Helicobacter pylori-induced indoleamine 2,3-dioxygenase activity in vivo is regulated by TGFB1 and CTLA4 polymorphisms","volume":"44","author":"Raitala","year":"2007","journal-title":"Mol. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.semcancer.2015.07.004_bib1120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1385\/IR:35:1:75","article-title":"Antibody diversification: mutational mechanisms and oncogenesis","volume":"35","author":"Frieder","year":"2006","journal-title":"Immunol. Res."},{"key":"10.1016\/j.semcancer.2015.07.004_bib1125","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal centers","volume":"30","author":"Victora","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"6944","key":"10.1016\/j.semcancer.2015.07.004_bib1130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature01760","article-title":"Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation","volume":"424","author":"Pham","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2015.07.004_bib1135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.biochem.76.061705.090740","article-title":"Molecular mechanisms of antibody somatic hypermutation","volume":"76","author":"Di Noia","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.semcancer.2015.07.004_bib1140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2013.08.003","article-title":"cell lymphocytosis and \u201cin situ\u201d lymphoma","volume":"24","author":"Karube","year":"2014","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.semcancer.2015.07.004_bib1145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/10428194.2011.605190","article-title":"The role of CD40\/CD40L and interferon regulatory factor 4 in Hodgkin lymphoma microenvironment","volume":"53","author":"Aldinucci","year":"2012","journal-title":"Leuk. Lymphoma"},{"issue":"12","key":"10.1016\/j.semcancer.2015.07.004_bib1150","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.4049\/jimmunol.1201363","article-title":"Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment","volume":"190","author":"Rawal","year":"2013","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.semcancer.2015.07.004_bib1155","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.semcancer.2015.07.004_bib1160","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/leu.2011.301","article-title":"Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells","volume":"26","author":"Ame-Thomas","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.semcancer.2015.07.004_bib1165","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.coi.2011.03.004","article-title":"T cell-independent B cell memory","volume":"23","author":"Defrance","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"9","key":"10.1016\/j.semcancer.2015.07.004_bib1170","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1084\/jem.20070447","article-title":"T cell-independent development and induction of somatic hypermutation in human IgM+ IgD+ CD27+ B cells","volume":"205","author":"Scheeren","year":"2008","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.semcancer.2015.07.004_bib1175","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.4049\/jimmunol.179.7.4929","article-title":"Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren's syndrome","volume":"179","author":"Bombardieri","year":"2007","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2015.07.004_bib1180","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/blood-2009-06-228015","article-title":"Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins","volume":"115","author":"Craig","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.semcancer.2015.07.004_bib1185","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/leu.2010.76","article-title":"B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis","volume":"24","author":"Craig","year":"2010","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.semcancer.2015.07.004_bib1190","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.semcancer.2013.09.004","article-title":"Marginal zone lymphomas and infectious agents","volume":"23","author":"Ferreri","year":"2013","journal-title":"Semin. Cancer Biol."},{"issue":"8","key":"10.1016\/j.semcancer.2015.07.004_bib1195","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1084\/jem.20030530","article-title":"Molecular mimicry between Helicobacter pylori antigens and H+, K+ \u2013 adenosine triphosphatase in human gastric autoimmunity","volume":"198","author":"Amedei","year":"2003","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.semcancer.2015.07.004_bib1200","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1182\/blood-2005-09-3679","article-title":"Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation","volume":"107","author":"Suarez","year":"2006","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.semcancer.2015.07.004_bib1205","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1182\/blood-2010-06-293266","article-title":"Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma","volume":"117","author":"Munari","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.semcancer.2015.07.004_bib1210","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0016-5085(99)70395-1","article-title":"Impaired T-cell regulation of B-cell growth in Helicobacter pylori \u2013 related gastric low-grade MALT lymphoma","volume":"117","author":"D\u2019Elios","year":"1999","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.semcancer.2015.07.004_bib1215","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrc3774","article-title":"The tumour microenvironment in B cell lymphomas","volume":"14","author":"Scott","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2015.07.004_bib1220","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2005-04-1510","article-title":"Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions","volume":"107","author":"Rimsza","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semcancer.2015.07.004_bib1225","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood-2005-11-4742","article-title":"Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival","volume":"108","author":"Roberts","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2015.07.004_bib1230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural innate and adaptive immunity to cancer","volume":"29","author":"Vesely","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.semcancer.2015.07.004_bib1235","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/ni0901-789","article-title":"The risk of autoimmunity associated with tumor immunotherapy","volume":"2","author":"Gilboa","year":"2001","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.semcancer.2015.07.004_bib1240","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.smim.2011.10.002","article-title":"Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions","volume":"23","author":"Yamaguchi","year":"2011","journal-title":"Semin. Immunol."},{"issue":"11","key":"10.1016\/j.semcancer.2015.07.004_bib1245","doi-asserted-by":"crossref","first-page":"6840","DOI":"10.4049\/jimmunol.178.11.6840","article-title":"CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model","volume":"178","author":"Elpek","year":"2007","journal-title":"J. Immunol."},{"issue":"21","key":"10.1016\/j.semcancer.2015.07.004_bib1250","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1200\/JCO.2005.05.5434","article-title":"Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma","volume":"24","author":"Cheng","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.semcancer.2015.07.004_bib1255","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/eji.201242590","article-title":"Autoimmunity-mediated antitumor immunity: tumor as an immunoprivileged self","volume":"42","author":"Miska","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"20","key":"10.1016\/j.semcancer.2015.07.004_bib1260","doi-asserted-by":"crossref","first-page":"10145","DOI":"10.1158\/0008-5472.CAN-06-1822","article-title":"Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2015.07.004_bib1265","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10428194.2013.804917","article-title":"Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltration","volume":"55","author":"Liu","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.semcancer.2015.07.004_bib1270","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.semcancer.2013.08.001","article-title":"The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity","volume":"24","author":"Ame-Thomas","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2015.07.004_bib1275","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3389\/fonc.2014.00349","article-title":"Myeloid-derived suppressor cells as therapeutic target in hematological malignancies","volume":"4","author":"De Veirman","year":"2014","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.semcancer.2015.07.004_bib1280","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.4049\/jimmunol.1201018","article-title":"Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth","volume":"189","author":"Schlecker","year":"2012","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.semcancer.2015.07.004_bib1285","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1158\/0008-5472.CAN-07-6621","article-title":"Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells","volume":"68","author":"Serafini","year":"2008","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2015.07.004_bib1290","doi-asserted-by":"crossref","first-page":"e995541","DOI":"10.1080\/2162402X.2014.995541","article-title":"Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma","volume":"4","author":"Sato","year":"2015","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/j.semcancer.2015.07.004_bib1295","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1182\/blood-2008-03-143776","article-title":"Mononuclear myeloid-derived \u201csuppressor\u201d cells express RAE-1 and activate natural killer cells","volume":"112","author":"Nausch","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2015.07.004_bib1300","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1038\/ncomms6057","article-title":"Dendritic cell-mediated survival signals in Emu-Myc B-cell lymphoma depend on the transcription factor C\/EBPbeta","volume":"5","author":"Rehm","year":"2014","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.semcancer.2015.07.004_bib1305","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2009-03-208215","article-title":"Mice deficient for CD137 ligand are predisposed to develop germinal center-derived B-cell lymphoma","volume":"114","author":"Middendorp","year":"2009","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.semcancer.2015.07.004_bib1310","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1182\/blood-2009-05-220111","article-title":"Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells","volume":"114","author":"Wilcox","year":"2009","journal-title":"Blood"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X15000632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X15000632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T16:07:26Z","timestamp":1589558846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X15000632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":131,"alternative-id":["S1044579X15000632"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2015.07.004","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microenvironment abnormalities and lymphomagenesis: Immunological aspects","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2015.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}